Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers

Simona Pichini, Mitona Pujadas, Emilia Marchei, Manuela Pellegrini, Jimena Fiz, Roberta Pacifici, Piergiorgio Zuccaro, Magi Farré, Rafael de la Torre

Research output: Contribution to journalArticleResearchpeer-review

45 Citations (Scopus)

Abstract

A procedure based on liquid chromatography-mass spectrometry (LC-MS) is described for determination of 3,4-methylenedioxymethamphetamine (MDMA), 2,5-dimethoxy-4-methyl-phenethylamine (2C-D), 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B), 1-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b'] difuran-4-yl)-2-aminoethane (2C-B-Fly), 4-ethylthio-2,5-dimethoxy-β-phenethylamine (2C-T-2), 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I), and 4-ethyl-2,5-dimethoxy-β-phenethylamine (2C-E), 1-(m-chlorophenyl)piperazine (m-CPP), 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DIPT) and 4-acetoxy-N,N-diisopropyltryptamine (4-acetoxy-DIPT) in urine of consumers using 3,4 methylendioxypropylamphetamine (MDPA) as internal standard. Sample preparation involved a solid-phase extraction procedure at pH 6 of both non-hydrolyzed and enzymatically hydrolyzed urine samples. Chromatography was performed on a C18 reversed-phase column using a linear gradient of 10 mM ammonium bicarbonate, pH 7.3 and acetonitrile as a mobile phase. Separated analytes were determined in LC-MS single ion monitoring mode using an atmospheric pressure ionization-electrospray ionization (ESI) interface. The assay was tested on urine samples from consumers of compounds under investigation (n = 32). Limits of quantification varied between 20 and 60 ng/mL for the different analytes under investigation. Calibration curves were linear to 2000 ng/mL for all the substances under investigation, with a minimum r2 > 0.99. At three concentrations spanning the linear dynamic range of the assay, mean recoveries ranged between 55.4 and 95.6% for the different analytes. Higher analytes concentrations in hydrolyzed samples showed the presence of conjugated compounds in urine. © 2008 Elsevier B.V. All rights reserved.
Original languageEnglish
Pages (from-to)335-342
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume47
DOIs
Publication statusPublished - 9 Jun 2008

Keywords

  • Designer drugs
  • Hallucinogen
  • LC-MS
  • Urine

Fingerprint

Dive into the research topics of 'Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers'. Together they form a unique fingerprint.

Cite this